Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 12
Submit an article Journal homepage
331
Views
15
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase

Lise-Marie MollardService d’Hématologie Clinique, Institut de Cancéro-Hématologie, CHRU de Brest, Brest, France;
,
Aurélie ChauveauLaboratoire d’Hématologie, CHRU de Brest, Brest, France;
,
Françoise Boyer-PerrardService des Maladies du Sang, CHU d’Angers, Brest, France;
,
Nathalie Douet-GuilbertLaboratoire de Cytogénétique, CHRU de Brest, Brest, France;
,
Roch HouotLaboratoire d’Anatomo-Pathologie, CHRU Brest, Brest, France;
,
Isabelle Quintin-RouéService d’Hématologie Clinique, CHU de Rennes, Brest, France;
,
Marie-Anne CouturierService d’Hématologie Clinique, CH de Saint-Brieuc, Brest, France;
,
Anaig DagorneService d’Hématologie Clinique, CH de Morlaix, Brest, France;
,
Mohamed MalouService de Médecine Interne, CH de Quimper, Brest, France;
,
Ronan Le CallochService d’Hématologie, CH de Lorient, Brest, France;
,
Odile LuycxLaboratoire d’Hématologie, CHU d’Angers, Brest, France
,
Sylvain ThepotService des Maladies du Sang, CHU d’Angers, Brest, France;
,
Mathilde HunaultService des Maladies du Sang, CHU d’Angers, Brest, France;
,
Gaelle GuillermService d’Hématologie Clinique, Institut de Cancéro-Hématologie, CHRU de Brest, Brest, France;
,
Christian BerthouService d’Hématologie Clinique, Institut de Cancéro-Hématologie, CHRU de Brest, Brest, France;
,
Valérie UgoService de Médecine Interne, CH de Quimper, Brest, France;
,
Éric LippertLaboratoire d’Hématologie, CHRU de Brest, Brest, France;
&
Jean-Christophe IanottoService d’Hématologie Clinique, Institut de Cancéro-Hématologie, CHRU de Brest, Brest, France; Correspondence[email protected]
 show all
Pages 2812-2820 | Received 12 Jun 2017, Accepted 04 Feb 2018, Published online: 04 Apr 2018

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jia Chen, Kefei Wang, Zhijian Xiao & Zefeng Xu. (2023) Efficacy and safety of combination therapies vs monotherapy of hypomethylating agents in accelerated or blast phase of Philadelphia negative myeloproliferative neoplasms: a systematic review and meta-analysis. Annals of Medicine 55:1, pages 348-360.
Read now
Alejandro Garcia-Horton, Dawn Maze, Caroline J. McNamara, Hassan Sibai, Vikas Gupta & Tracy Murphy. (2021) Azacitidine and venetoclax for the treatment of accelerated and blast phase myeloproliferative neoplasms and chronic myelomonocytic leukemia: a case series. Leukemia & Lymphoma 62:6, pages 1525-1527.
Read now

Articles from other publishers (13)

Ayalew Tefferi, Hassan Alkhateeb & Naseema Gangat. (2023) Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm. Blood Cancer Journal 13:1.
Crossref
Solomon Gyabaah, Eunice Agyemang Ahmed, Adwoa Agyemang Adu-Gyamfi, Frederick Nkrumah Gyabaah, Afia Serwaa Bonsu, Ameyaw Prince Addo & Ohene Kwaku Opare Sem. (2023) Polycythemia vera disease profile in an African population—experience from a tertiary facility in Ghana. SAGE Open Medicine 11.
Crossref
Jan Philipp Bewersdorf & Raajit K. Rampal. (2022) Hitting the brakes on accelerated and blast-phase myeloproliferative neoplasms: current and emerging concepts. Hematology 2022:1, pages 218-224.
Crossref
Chandan Saha, Luke Attwell, Claire N. Harrison & Donal P. McLornan. (2022) Addressing the challenges of accelerated and blast phase myeloproliferative neoplasms in 2022 and beyond. Blood Reviews 55, pages 100947.
Crossref
Paul Chauvet, Olivier Nibourel, Celine Berthon, Laure Goursaud, Benjamin Carpentier, Pauline Lionne-Huyghe, Mathieu Wemeau & Bruno Quesnel. (2022) Resurgence of myeloproliferative neoplasm in patients in remission from blast transformation after treatment with hypomethylating agents. Leukemia Research 118, pages 106871.
Crossref
Antoine N. Saliba & Naseema Gangat. (2022) Accelerated and blast phase myeloproliferative neoplasms. Best Practice & Research Clinical Haematology 35:2, pages 101379.
Crossref
Juan-Carlos Hernández-Boluda, David Martínez-Cuadrón, Arturo Pereira, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Sandra Casal-Marini, Josefina Serrano, Joaquín Martínez-López, Juan Bergua, Lorenzo Algarra, Teresa Bernal, Jose-Luis López-Lorenzo, Mercedes Colorado, Aurelio López, Mar Tormo, María-José Sayas, Fernanda Trigo, María López-Pavía, José-Antonio Pérez-Simón, Esperanza Lavilla-Rubira, Carlos Rodríguez-Medina, Juan-Ignacio Rodríguez-Gutiérrez, Miguel-Angel Sanz-Caballer & Pau Montesinos. (2022) Acute leukemia arising from myeloproliferative or myelodysplastic/myeloproliferative neoplasms: A series of 372 patients from the PETHEMA AML registry. Leukemia Research 115, pages 106821.
Crossref
Omar A. Shahin, Helen T. Chifotides, Prithviraj Bose, Lucia Masarova & Srdan Verstovsek. (2021) Accelerated Phase of Myeloproliferative Neoplasms. Acta Haematologica 144:5, pages 484-499.
Crossref
Damien Luque Paz, Rébecca Jouanneau-CourvilleJérémie Riou, Jean-Christophe IanottoFrançoise BoyerAurélie ChauveauMaxime RenardJean-Claude Chomel, Emilie CayssialsMaria-Pilar Gallego-HernanzCédric PastoretAnne MuratiFrédéric CourtierMarie-Christine RousseletIsabelle Quintin-RouéLaurane Cottin, Corentin Orvain, Sylvain ThépotJean-Marie Chrétien, Yves DelnesteNorbert Ifrah, Odile Blanchet, Mathilde Hunault-BergerEric Lippert & Valérie Ugo. (2020) Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation. Blood Advances 4:19, pages 4887-4897.
Crossref
Alessandro Andriani, Elena Elli, Giulio Trapè, Nicoletta Villivà, Luana Fianchi, Ambra Di Veroli, Pasquale Niscola, Antonia Centra, Barbara Anaclerico, Guido Montanaro, Vincenza Martini, Andrea Aroldi, Ida Carmosino, Maria Teresa Voso, Massimo Breccia, Marco Montanaro, Roberto Foà & Roberto Latagliata. (2019) Treatment of Philadelphia‐negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors. Hematological Oncology 37:3, pages 291-295.
Crossref
Hans Carl Hasselbalch & Morten Orebo Holmström. (2018) Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?. Seminars in Immunopathology 41:1, pages 5-19.
Crossref
Bridget K. Marcellino, Ronald Hoffman, Joseph Tripodi, Min Lu, Heidi Kosiorek, John Mascarenhas, Raajit K. Rampal, Amylou Dueck & Vesna Najfeld. (2018) Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53. Blood Advances 2:24, pages 3581-3589.
Crossref
Elisabetta Abruzzese, Malgorzata Monika  Trawinska, Benedetta Neri, Francesco Bondanini, Stefano Fratoni, Andrea Tendas, Laura Scaramucci, Agostina Siniscalchi, Marco Giovannini, Roberto Palumbo, Paolo de Fabritiis & Pasquale Niscola. (2018) Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm. Acta Haematologica 140:4, pages 231-233.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.